Search

everythinglearnresearchcommunity

for

Search:↓

Scientists successfully created and analyzed the structure of a part of the human androgen receptor with specific modulators and a peptide to understand how it binds differently in various tissues.

Augmented reality improves vascular surgery by reducing risks and operation times.

The ABI1 gene contributes to prostate cancer progression and treatment resistance.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

Minoxidil and finasteride can slow hair loss and stimulate regrowth, but won't restore all lost hair or reverse complete baldness.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

Drospirenone is a unique progestin with anti-water retention and potential blood pressure benefits, used in birth control and hormone therapy.

Nano-PROTACs could improve drug targeting and delivery by using nanotechnology.

5α-reductase inhibitors, like finasteride and dutasteride, effectively treat BPH, male baldness, and hirsutism, with potential for acne and prostate cancer prevention.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

The compound 4c showed strong potential as an anticancer agent.

Honokiol might help reduce male skin aging by maintaining testosterone levels.

Deformable vesicular carriers improve drug delivery for skin conditions and systemic treatments.

Bicalutamide effectively treats prostate cancer but needs careful monitoring for side effects.

Current treatments for male pattern baldness include minoxidil and finasteride, with new options being developed.

The new "differential stripping" method effectively measures how much substance gets into hair follicles.

Cell aging can be both good and bad for tissue repair.

Cellular senescence has both cancer-blocking and cancer-promoting effects, and targeting senescent cells may improve health and lifespan.

Cytochrome P-450 enzymes in the skin help break down various substances and could be targeted to treat skin conditions.

Current research explores hair growth drugs, while future research aims for personalized treatments.

Follicular targeting could improve hirsutism treatment by focusing directly on hair follicles.

Targeted siRNA therapy may be a promising treatment for KID syndrome by reducing mutant gene expression and improving cell communication.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

Cows can safely graze after a nuclear incident if iodine exposure is managed, as doses below 30 Gy don't harm them long-term.

Potassium channel openers are effective in treating heart conditions, high blood pressure, pulmonary diseases, bladder issues, and hair loss, but more selective drugs are needed.

Anabolic steroid abuse can cause sexual, fertility, and health problems.

Ozone therapy might improve cancer treatment and reduce its side effects.

COVID-19 may worsen Parkinson's disease by affecting certain brain proteins.

Drug repositioning is becoming more targeted and efficient with new technologies, offering personalized treatment options and growing interest in the field.